BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chouillard E, Ata T, De Jonghe B, Maggiori L, Helmy N, Coscas Y, Outin H. Staged laparoscopic adjuvant intraperitoneal chemohyperthermia after complete resection for locally advanced colorectal or gastric cancer: a preliminary experience. Surg Endosc 2009;23:363-9. [PMID: 18461388 DOI: 10.1007/s00464-008-9946-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers AGJ, Brandt A, Bremers AJA, Burger JWA, Fabry HFJ, Ferenschild F, Festen S, van Grevenstein WMU, Hemmer PHJ, de Hingh IHJT, Kok NFM, Musters GD, Schoonderwoerd L, Tuynman JB, van de Ven AWH, van Westreenen HL, Wiezer MJ, Zimmerman DDE, van Zweeden AA, Dijkgraaf MGW, Tanis PJ; COLOPEC collaborators group. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol 2019;4:761-70. [PMID: 31371228 DOI: 10.1016/S2468-1253(19)30239-0] [Cited by in Crossref: 78] [Cited by in F6Publishing: 34] [Article Influence: 26.0] [Reference Citation Analysis]
2 Chouillard E, Greco V, Tsiminikakis N. Peritoneal carcinomatosis of colorectal origin: is it really an end-stage disease? Tech Coloproctol 2013;17:619-21. [PMID: 24061499 DOI: 10.1007/s10151-013-1063-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Pinto A, Eveno C, Pocard M. Update on clinical trials in colorectal cancer peritoneal metastasis. International Journal of Hyperthermia 2017;33:543-7. [DOI: 10.1080/02656736.2017.1289565] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
4 Sloothaak DA, Mirck B, Punt CJ, Bemelman WA, van der Bilt JD, D'Hoore A, Tanis PJ. Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: A systematic review. Br J Cancer. 2014;111:1112-1121. [PMID: 25025964 DOI: 10.1038/bjc.2014.369] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
5 Kyang LS, Valle SJ, Alzahrani NA, Morris DL. Prevention of peritoneal recurrence in high-risk colorectal cancer and evidence of T4 status as a potential risk factor: Prevention of high-risk CRPM. ANZ Journal of Surgery 2018;88:975-81. [DOI: 10.1111/ans.14428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP, Yun SH, Kim JG, Kang BW. Laparoscopic cytoreductive surgery and early postoperative intraperitoneal chemotherapy for patients with colorectal cancer peritoneal carcinomatosis: initial results from a single center. Surg Endosc. 2014;28:1555-1562. [PMID: 24368743 DOI: 10.1007/s00464-013-3351-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
7 Sloothaak DA, Gardenbroek TJ, Crezee J, Bemelman WA, Punt CJ, Buskens CJ, Tanis PJ. Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis. Eur J Surg Oncol. 2014;40:1453-1458. [PMID: 25073662 DOI: 10.1016/j.ejso.2014.06.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
8 Bhatt A, Bhamre R, Rohila J, Kalikar V, Desouza A, Saklani A. Patients with extensive regional lymph node involvement (pN2) following potentially curative surgery for colorectal cancer are at increased risk for developing peritoneal metastases: a retrospective single-institution study. Colorectal Dis 2019;21:287-96. [PMID: 30457185 DOI: 10.1111/codi.14481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Tan G, Wong J. Surgical management and hyperthermic intraperitoneal chemotherapy for locally advanced colorectal cancer. J Gastrointest Oncol. 2020;11:508-512. [PMID: 32655929 DOI: 10.21037/jgo.2019.12.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Di Vita M, Cappellani A, Piccolo G, Zanghì A, Cavallaro A, Bertola G, Bolognese A, Facchini G, D’Aniello C, Di Francia R. The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer: between lights and shadows. Anticancer Drugs. 2015;26:123-138. [PMID: 25406023 DOI: 10.1097/cad.0000000000000179] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
11 Klaver CEL, Stam R, Sloothaak DAM, Crezee J, Bemelman WA, Punt CJA, Tanis PJ. Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives. Oncotarget. 2017;8:51200-51209. [PMID: 28881641 DOI: 10.18632/oncotarget.17158] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]